IL108623A0 - Silylated acetylcholinesterase inhibitors - Google Patents

Silylated acetylcholinesterase inhibitors

Info

Publication number
IL108623A0
IL108623A0 IL10862394A IL10862394A IL108623A0 IL 108623 A0 IL108623 A0 IL 108623A0 IL 10862394 A IL10862394 A IL 10862394A IL 10862394 A IL10862394 A IL 10862394A IL 108623 A0 IL108623 A0 IL 108623A0
Authority
IL
Israel
Prior art keywords
silylated
acetylcholinesterase inhibitors
compounds
methods
acetylcholinesterase
Prior art date
Application number
IL10862394A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL108623A0 publication Critical patent/IL108623A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
IL10862394A 1993-02-16 1994-02-11 Silylated acetylcholinesterase inhibitors IL108623A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93400385A EP0611769A1 (fr) 1993-02-16 1993-02-16 Inhibiteurs d'acétylcholinerase silylés

Publications (1)

Publication Number Publication Date
IL108623A0 true IL108623A0 (en) 1994-05-30

Family

ID=8214682

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10862394A IL108623A0 (en) 1993-02-16 1994-02-11 Silylated acetylcholinesterase inhibitors

Country Status (19)

Country Link
EP (2) EP0611769A1 (fr)
JP (1) JP3516955B2 (fr)
KR (1) KR100336547B1 (fr)
CN (1) CN1043575C (fr)
AT (1) ATE152725T1 (fr)
AU (1) AU672885B2 (fr)
CA (1) CA2154870C (fr)
DE (1) DE69403068T2 (fr)
DK (1) DK0684951T3 (fr)
ES (1) ES2104358T3 (fr)
FI (1) FI111461B (fr)
GR (1) GR3024151T3 (fr)
HU (1) HUT72736A (fr)
IL (1) IL108623A0 (fr)
MX (1) MX9401175A (fr)
NO (1) NO305517B1 (fr)
NZ (1) NZ262247A (fr)
WO (1) WO1994019356A1 (fr)
ZA (1) ZA94925B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627400A1 (fr) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Inhibiteurs aromatiques d'acétylcholinesterase
CN100431539C (zh) * 2004-01-12 2008-11-12 和泓生物技术（上海）有限公司 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (fr) 2007-04-18 2014-12-24 Probiodrug AG Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
NZ602312A (en) 2010-03-10 2014-02-28 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (fr) 2010-04-21 2011-10-27 Probiodrug Ag Nouveaux inhibiteurs
EP2686313B1 (fr) 2011-03-16 2016-02-03 Probiodrug AG Dérivés de benzimidazole en tant qu'inhibiteurs de la glutaminyl cyclase
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ， インコーポレイテッド 認知機能を改善するための方法および組成物
WO2014144663A1 (fr) 2013-03-15 2014-09-18 The Johns Hopkins University Procédés et compositions pour améliorer la fonction cognitive
WO2016191288A1 (fr) 2015-05-22 2016-12-01 Agenebio, Inc. Compositions pharmaceutiques de lévétiracétam à libération prolongée
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
CN112047973B (zh) * 2019-06-06 2022-11-18 上海科技大学 一种大麻素类化合物，其制备方法、组合物和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403713A1 (fr) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Inhibiteurs d'acétylcholinestérase

Also Published As

Publication number Publication date
DK0684951T3 (da) 1997-05-26
WO1994019356A1 (fr) 1994-09-01
FI953851L (fi) 1995-08-15
JPH08507059A (ja) 1996-07-30
NO305517B1 (no) 1999-06-14
KR960701068A (ko) 1996-02-24
KR100336547B1 (ko) 2002-11-02
CN1043575C (zh) 1999-06-09
JP3516955B2 (ja) 2004-04-05
DE69403068D1 (en) 1997-06-12
EP0684951B1 (fr) 1997-05-07
NO953201D0 (no) 1995-08-15
HUT72736A (en) 1996-05-28
ES2104358T3 (es) 1997-10-01
AU672885B2 (en) 1996-10-17
CA2154870A1 (fr) 1994-09-01
ATE152725T1 (de) 1997-05-15
FI111461B (fi) 2003-07-31
EP0684951A1 (fr) 1995-12-06
FI953851A0 (fi) 1995-08-15
EP0611769A1 (fr) 1994-08-24
ZA94925B (en) 1994-08-25
NZ262247A (en) 1996-01-26
CA2154870C (fr) 1998-10-27
NO953201L (no) 1995-08-15
MX9401175A (es) 1994-08-31
DE69403068T2 (de) 1997-12-11
CN1117733A (zh) 1996-02-28
GR3024151T3 (en) 1997-10-31
AU6164194A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
IL109863A0 (en) Aromatic acetylcholinesterase inhibitors
ZA94925B (en) Silylated acetylcholinesterase inhibitors
GB9514451D0 (en) Sustained-release formulation
HUT71550A (en) Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis
AU658296B2 (en) 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors
HU9500933D0 (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
AU4034593A (en) (N-phthalimidoalkyl)piperidines for the treatment of psychoses
EP0630383A4 (fr) Procedes de traitement des diabetes.
EP0674707A4 (fr) Composes et methodes de traitement des leucemies.
NZ247406A (en) Treatment of osteoporosis with 1 alpha, 24(r)-dihydroxy-22(e)-dehydro-vitamin d3
AU6410394A (en) Method of treating addictive behaviors
HU9301169D0 (en) Method for improving flame-proofness of plastics by means of addition of guanidine-barbiturates and/or guanidine-thiobarbiturates as burning inhibitors, flame-proof plastics containing said compounds as well as these compounds
ZA912236B (en) Hydroxymethyl-indolizidines and quinolizidines
GB9217547D0 (en) Leather treatment compositions
GB9317989D0 (en) Treatment of laminitis
GB2269523B (en) Treating hides
HU9301187D0 (en) Method for treating tumours being dependent of gar-transformylase
EP0608702A3 (fr) Procédé de traitement des noisettes.
EP0932406A4 (fr) Methodes de traitement ou de prevention de la cystite interstitielle
GB9308853D0 (en) Novel method of treatment